Evidence map›Paper›PMID 30680550›Full record

ArticleJournal of nephrology2019

Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".

Agnieszka Pozdzik, Naim Maalouf, Emmanuel Letavernier, Isabelle Brocheriou, Jean-Jacques Body, Benjamin Vervaet, Carl Van Haute, Johanna Noels, Romy Gadisseur, Vincent Castiglione and 4 more

Abstract readConference Proceedings
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Agnieszka PozdzikKidney Stones Clinic, Nephrology and Dialysis Clinic, Centre Hospitalier Universitaire, Brugmann Hospital, Brussels, Belgium. Agnieszka.Pozdzik@chu-brugmann.be.
Naim MaaloufDepartment of Internal Medicine, and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Emmanuel LetavernierService des explorations fonctionnelles multidisciplinaires, Tenon Hospital, AP_HP, Paris, France.
Isabelle BrocheriouDepartment of Pathology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.
Jean-Jacques BodyDepartment of Internal Medicine, Brugmann Hospital, Centre Hospitalier Universitaire, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Benjamin VervaetLaboratory of Pathophysiology, Antwerp University, Antwerp, Belgium.
Carl Van HauteDepartment of Urology, Brugmann Hospital, Centre Hospitalier Universitaire, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Johanna NoelsDepartment of Urology, Brugmann Hospital, Centre Hospitalier Universitaire, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Romy GadisseurDepartment of Clinical Chemistry, EuSpLM, Laboratories "Emergency, Allergy, Urolithiasis", University Hospital of Liège, Liège, Belgium.
Vincent CastiglioneDepartment of Clinical Chemistry, EuSpLM, Laboratories "Emergency, Allergy, Urolithiasis", University Hospital of Liège, Liège, Belgium.
Frédéric CottonDepartment of Clinical Chemistry, LHUB-ULB, Brussels, Belgium.
Giovanni GambaroDivision of Nephrology and Dialysis, Gemelli University hospital, Rome, Italy.
Michel DaudonService des explorations fonctionnelles multidisciplinaires, Tenon Hospital, AP_HP, Paris, France.
Khashayar SakhaeeDepartment of Internal Medicine, and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Funding

Amgen Belgium (MDeon Visa 17/V2/10119/005925)Baxter Belgium (MDeon Visa 17/V2/10119/005925)BellcoMedtronic Belgium (MDeon Visa 17/V2/10119/005925)BioHealth Italy (MDeon Visa 17/V2/10119/005925)Menarini Belgium (MDeon Visa 17/V2/10119/005925)Nippro Belgium (MDeon Visa 17/V2/10119/005925)Vifor Fresenius Medical Care Renal Pharma Belgique (MDeon Visa 17/V2/10119/005925)
6 · The paper itself

Abstract

A symposium on kidney stones and mineral metabolism held on December 2017 in Brussels, Belgium was the first international multidisciplinary conference of the International Collaborative Network on Kidney Stones and Mineral Metabolism. This meeting addressed epidemiology, underlying pathophysiological mechanisms, genetics, pathological, as well as clinical and research topics. The participants included clinicians and recognized experts in the field from Europe and the United States interacted closely during the symposium which promoted a chance to explore new frontiers in the field of kidney stone disease. This manuscript summarizes some of the major highlights of the meeting.

Indexed as

CalciumCrystallizationDecision TreesHumansKidney CalculiMineralsNephrocalcinosisNephrolithiasisCalciumMineralsChronic kidney diseaseHypercalcemiaHypercalciuriaHyperoxaluriaKidney stonesNephrocalcinosisNephrolithiasis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.